Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Davis

Showing results (21-30 of 88) with videos related to

Pageof 9
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|March 17, 2021
Population pharmacokinetic characteristics of cemiplimab in patients with advanced malignanciesFeng Yang, Anne J Paccaly, Ronda K Rippley, et al.
Clinical Pharmacology in Drug Development|March 26, 2025
Target-Mediated Modeling of Alirocumab in Adolescents and Children ≥8 to <12 Years of Age Using Phase II and III DataPavel Kovalenko, Lutz Harnisch, Jeanne Mendell, et al.
Journal of Lower Genital Tract Disease|February 29, 2012
Angiomyofibroblastoma of the vulva: a case report of a pedunculated variant and review of the literatureShireen Madani Sims, Kathryn Stinson, Frederick W McLean, et al.
Clinical and Translational Science|July 31, 2024
Dupilumab: Mechanism of action, clinical, and translational scienceMarc R McCann, Matthew P Kosloski, Christine Xu, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2021
Population pharmacokinetic analysis of dupilumab in adult and adolescent patients with asthmaLi Zhang, Yue Gao, Meng Li, et al.
Journal of Lower Genital Tract Disease|July 2, 2010
Vulvar lymphangioma circumscriptum: a report of 3 cases, 2 associated with vulvar carcinoma and 1 with hidradenitis suppurativaShireen Madani Sims, Frederick W McLean, John D Davis, et al.
Female Pelvic Medicine & Reconstructive Surgery|September 17, 2016
Identifying Gaps and Inconsistencies in Urogynecologic Surgical Training of Obstetrics and Gynecology ResidentsEmily E Weber LeBrun, Hazel Asumu, Anne M Richardson, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 6, 2025
Pharmacokinetics of Odronextamab, A Bispecific T-Cell-Engaging Antibody, in Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin LymphomaMarçal Bravo Padros, Daniela J Conrado, Kamal Srinivasan, et al.
Pharmaceutical Research|September 18, 2024
Population Pharmacokinetics of Casirivimab and Imdevimab in Pediatric and Adult Non-Infected Individuals, Pediatric and Adult Ambulatory or Hospitalized Patients or Household Contacts of Patients Infected with SARS-COV-2Kuan-Ju Lin, Kenneth C Turner, Maria Rosario, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 17, 2022
Population pharmacokinetics modeling and exposure-response analyses of cemiplimab in patients with recurrent or metastatic cervical cancerJenny-Hoa Nguyen, Daniel Epling, Nancy Dolphin, et al.
Pageof 9

Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Journal of Pharmacokinetics and Pharmacodynamics|March 17, 2021
Population pharmacokinetic characteristics of cemiplimab in patients with advanced malignanciesFeng Yang, Anne J Paccaly, Ronda K Rippley, et al.
Clinical Pharmacology in Drug Development|March 26, 2025
Target-Mediated Modeling of Alirocumab in Adolescents and Children ≥8 to <12 Years of Age Using Phase II and III DataPavel Kovalenko, Lutz Harnisch, Jeanne Mendell, et al.
Journal of Lower Genital Tract Disease|February 29, 2012
Angiomyofibroblastoma of the vulva: a case report of a pedunculated variant and review of the literatureShireen Madani Sims, Kathryn Stinson, Frederick W McLean, et al.
Clinical and Translational Science|July 31, 2024
Dupilumab: Mechanism of action, clinical, and translational scienceMarc R McCann, Matthew P Kosloski, Christine Xu, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 27, 2021
Population pharmacokinetic analysis of dupilumab in adult and adolescent patients with asthmaLi Zhang, Yue Gao, Meng Li, et al.
Journal of Lower Genital Tract Disease|July 2, 2010
Vulvar lymphangioma circumscriptum: a report of 3 cases, 2 associated with vulvar carcinoma and 1 with hidradenitis suppurativaShireen Madani Sims, Frederick W McLean, John D Davis, et al.
Female Pelvic Medicine & Reconstructive Surgery|September 17, 2016
Identifying Gaps and Inconsistencies in Urogynecologic Surgical Training of Obstetrics and Gynecology ResidentsEmily E Weber LeBrun, Hazel Asumu, Anne M Richardson, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 6, 2025
Pharmacokinetics of Odronextamab, A Bispecific T-Cell-Engaging Antibody, in Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin LymphomaMarçal Bravo Padros, Daniela J Conrado, Kamal Srinivasan, et al.
Pharmaceutical Research|September 18, 2024
Population Pharmacokinetics of Casirivimab and Imdevimab in Pediatric and Adult Non-Infected Individuals, Pediatric and Adult Ambulatory or Hospitalized Patients or Household Contacts of Patients Infected with SARS-COV-2Kuan-Ju Lin, Kenneth C Turner, Maria Rosario, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 17, 2022
Population pharmacokinetics modeling and exposure-response analyses of cemiplimab in patients with recurrent or metastatic cervical cancerJenny-Hoa Nguyen, Daniel Epling, Nancy Dolphin, et al.
Pageof 9